Coagulopathy in a patient with X-linked hyper-IgM syndrome who developed Kaposi's sarcoma.
Nagasawa
Masayuki
M
Itoh
Sukeyuki
S
Sawada
Yasuyuki
Y
Morio
Tomohiro
T
Nonoyama
Shigeaki
S
Mizutani
Shuki
S
D000293:Adolescent; D000970:Antineoplastic Agents / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002066:Busulfan / Q000008:administration & dosage; D041321:Chromosomes, Human, X; D003520:Cyclophosphamide / Q000008:administration & dosage; D006801:Humans; D007075:Immunoglobulin M / Q000097:blood*; D007153:Immunologic Deficiency Syndromes / Q000150:complications* / Q000235:genetics / Q000276:immunology; D008297:Male; D012514:Sarcoma, Kaposi / Q000188:drug therapy / Q000209:etiology*; D016896:Treatment Outcome
D000970:Antineoplastic Agents; D007075:Immunoglobulin M; D003520:Cyclophosphamide; D002066:Busulfan